Pathology

Uzm. Dr. Gamze Usul

Doctor and researcher Başakşehir Çam ve Sakura Şehir Hastanesi İstanbul
Breast Neoplasms

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPathologysaglik.gov.trFrom source
  • InstitutionBaşakşehir Çam ve Sakura Şehir Hastanesisaglik.gov.trFrom source
  • Area of workBreast NeoplasmsExtracted from 2 publications · Model version —From source
  • Publications9 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0003-2264-8417ORCIDFrom source
  • Last synchronised5 November 2026 10:37https://camsakurasehir.saglik.gov.tr/TR-1501419/gorev-yapan-hekimlerimiz.html#gamze-usulsaglik.gov.tr

Scientific work

Publications on Breast Neoplasms

9 publications
Publications by year Most: 3, in 2025
  1. 2017: 1 publication
  2. 2018: 0 publications
  3. 2019: 0 publications
  4. 2020: 0 publications
  5. 2021: 1 publication
  6. 2022: 0 publications
  7. 2023: 1 publication
  8. 2024: 1 publication
  9. 2025: 3 publications
  10. 2026: 2 publications
  1. Clinicopathological Predictors of Axillary Pathological Complete Response and Its Prognostic Significance in Clinically Node-Positive (cN+), HER2-Positive Breast Cancer Following Neoadjuvant Therapy

    Medicina, 2026

    DOI 10.3390/medicina62010200 PMID 41597486 Open-access full textSource: OpenAlex

  2. Prognostic but not predictive: the clinical implications of androgen receptor expression in breast cancer patients undergoing neoadjuvant chemotherapy

    Future Oncology, 2026

    DOI 10.1080/14796694.2026.2696936 PMID 42376794 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  3. Predicción de la respuesta completa a la quimiorradioterapia neoadyuvante en el cáncer de recto localmente avanzado: papel de los parámetros volumétricos basales de la PET/TC con [18F]FDG y los marcadores inflamatorios

    Revista Española de Medicina Nuclear e Imagen Molecular, 2025

    DOI 10.1016/j.remn.2025.500113 1 citation (OpenAlex) Source: OpenAlex

  4. Relation Between Primary Tumor Suvmax Value, Ki-67 Proliferation Index and Axillary Metastasis in Patients with Triple Negative Breast Cancer

    Bagcilar Medical Bulletin, 2025

    DOI 10.4274/bmb.galenos.2025.69885 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  5. Predicting complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: The role of baseline volumetric 18F-FDG PET/CT parameters and inflammatory markers

    Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2025

    DOI 10.1016/j.remnie.2025.500113 PMID 39921167 2 citations (Europe PMC) Source: OpenAlex

  6. The Association of Neuroendocrine Differentiation with MicroRNA 21 and MicroRNA let7f Expression and the Clinicopathological Parameters in Primary Invasive Breast Carcinomas with Neuroendocrine Features

    Diagnostics, 2024

    DOI 10.3390/diagnostics14192211 PMID 39410615 Open-access full textSource: ORCID

  7. Pd-l1 assessment in needle core biopsies of non-small cell lung cancer: interpathologist agreement and potential associated histopathological features

    Turkish Journal of Pathology, 2023

    DOI 10.5146/tjpath.2023.01609 PMID 37614090 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  8. NÖROENDOKRİN ÖZELLİKLER GÖSTEREN PRİMER İNVAZİV MEME KARSİNOMLARINDA, NÖROENDOKRİN DİFERANSİASYON YAYGINLIĞININ MİKRORNA 21 VEMİKRORNA LET7F EKSPRESYONU YANI SIRA KLİNİKOPATOLOJİK PARAMETRELER İLE İLİŞKİSİ

    Çanakkale Onsekiz Mart University AVESIS, 2021

    Source: OpenAlex

  9. Solitary fibrous tumours of the prostate: A case report

    2017

    DOI 10.26226/morressier.596cd2b8d462b802923882b8 Source: OpenAlex